JA, E., M, B., G, M., AJ, M., VG, B., KW, B., . . . N, K. (2019). HCV Eradication with Direct-Acting Antivirals Does Not Impact HCC Progression on the Waiting List or HCC Recurrence after Liver Transplantation. Canadian journal of gastroenterology & hepatology, 2019, 2509059. https://doi.org/10.1155/2019/2509059
Chicago Style (17th ed.) CitationJA, Emamaullee, Bral M, Meeberg G, Montano-Loza AJ, Bain VG, Burak KW, Bigam D, Shapiro AMJ, and Kneteman N. "HCV Eradication with Direct-Acting Antivirals Does Not Impact HCC Progression on the Waiting List or HCC Recurrence After Liver Transplantation." Canadian Journal of Gastroenterology & Hepatology 2019 (2019): 2509059. https://doi.org/10.1155/2019/2509059.
MLA (9th ed.) CitationJA, Emamaullee, et al. "HCV Eradication with Direct-Acting Antivirals Does Not Impact HCC Progression on the Waiting List or HCC Recurrence After Liver Transplantation." Canadian Journal of Gastroenterology & Hepatology, vol. 2019, 2019, p. 2509059, https://doi.org/10.1155/2019/2509059.